LifeScience Clinical & Diagnostic
TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab TU2218 demonstrated a favorable safety and a synerget...
March 12, 2024 | News
Eisai Co., Ltd. announced a significant step forward in the fight against Alzheimer's disease (AD) today, with its U.S. subsidiary Eisai Inc. committing up...
March 07, 2024 | News
Under the leadership of Dr. Frank Huang, Chairman and CEO, BioGate disclosed that their in-house research and development team has engineered BGX by integr...
March 07, 2024 | News
Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...
March 06, 2024 | News
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
March 06, 2024 | News
Telix Pharmaceuticals announced its acquisition of radioisotope production technology firm ARTMS Inc. ("ARTMS"), including its advanced cyclotron-based iso...
March 05, 2024 | News
Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to CBL-514 for Dercum...
March 05, 2024 | News
-Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the launch of the NAVigate-HPV Registry. This innov...
March 04, 2024 | News
In a compelling conversation with BioPharma APAC, Dr. David Bunka, the Chief Scientific Officer (CSO) of Aptamer Group, unveils an ambitious endeav...
March 01, 2024 | Interview
While they are identified and addressed differently around the world, there are over known 6,000 rare diseases – characterized by a wide range of dis...
February 29, 2024 | News
Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...
February 26, 2024 | News
CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...
February 26, 2024 | News
The trial also successfully met its key secondary endpoints, including the overall response rate, the percentage of subjects achieving a clinical activity ...
February 20, 2024 | News
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that Japan's Ministry of Health, Labour a...
February 19, 2024 | News
Most Read
Bio Jobs
News
Editor Picks